XKRX
006125
Market cap967mUSD
Oct 08, Last price
43,900.00KRW
1D
-0.68%
1Q
13.29%
Jan 2017
162.43%
Name
SK Discovery Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 1969 and based in Seongnam-si, South Korea, SK Discovery Co., Ltd. operates a diverse range of businesses both domestically and internationally through its various subsidiaries. The company specializes in the development and supply of environmentally conscious materials, including biomaterials, advanced composites, high-performance substances, and energy-efficient solutions. It also plays a significant role in public health by providing healthcare solutions, such as vaccines and pharmaceuticals, for the treatment, prevention, and diagnosis of diseases. Furthermore, SK Discovery's portfolio extends to the energy and chemicals sector, encompassing the management of liquefied petroleum gas (LPG) storage, the operation of tank terminals, and power generation. Its real estate division is responsible for developing a variety of properties, including commercial spaces, office buildings, urban and high-end residential complexes, as well as infrastructure for renewable energy, such as solar and wind power plants. The company adopted its current name, SK Discovery Co., Ltd., in December 2017, having previously been known as SK Chemicals Co., Ltd.
Key people
Co-President, Director · since 2025
Co-President, Co-Chief Executive Officer, Director · since 2024
Co-Chief Executive Officer, Vice Chairman, Director · since 2018
Director · since 2023
Jae Sang Gu
Non-Executive Independent Director · since 2024
Jin Yil Kim
Non-Executive Independent Director
Hyeon Jin Kim
Non-Executive Independent Director · since 2022
Yong Jun Kim
Non-Executive Independent Director · since 2022
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||